Ország: Izrael
Nyelv: angol
Forrás: Ministry of Health
BORTEZOMIB
ABIC MARKETING LTD, ISRAEL
L01XX32
POWDER FOR SOLUTION FOR INJECTION
BORTEZOMIB 1 MG
I.V
Required
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
BORTEZOMIB
Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation
2017-07-04